Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.
Saved in:
| Title: | Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study. |
|---|---|
| Authors: | Ørbo HS; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., de Matos Kasahara T; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Wolf AS; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Bjørlykke KH; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jyssum I; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Tveter AT; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Solum G; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kjønstad IF; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Bhandari S; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Christensen IE; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kvien TK; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Lind A; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Kared H; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Jahnsen J; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Haavardsholm EA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Munthe LA; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Centre for B Cell Malignancies, and Precision Immunotherapy Alliance (PRIMA), University of Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Section for Public Health, Inland Norway University of Applied Sciences, Elverum, Norway., Vaage JT; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Mjaaland S; Section of Immunology, Norwegian Institute of Public Health, Oslo, Norway., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Grødeland G; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital, Oslo, Norway., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway. |
| Source: | The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Nov 15; Vol. 48, pp. 101121. Date of Electronic Publication: 2024 Nov 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
